Form 4 for TWST Twist Bioscience Corp
Accepted 2022-04-18 00:00:00 ET · period of report 2022-04-14 · accession 0001214659-22-005391 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-04-18 | 2022-04-14 | TWST | THORBURN JAMES M | CFO | S - Sale+OE | $42.85 | -6,620 | 46.7K | -12% | -$283.7K |
| DM | 2022-04-18 | 2022-04-14 | TWST | THORBURN JAMES M | CFO | M - OptEx | $17.88 | +6,620 | 50.2K | +15% | +$118.4K |
| DM | 2022-04-18 | 2022-04-14 | TWST | THORBURN JAMES M | CFO | M - OptEx | $0.00 | -6,620 | 38.9K | -15% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-14 | S | D | 5,493 | $42.71 | 47,815 | D | — | — | (F2) Represents the weighted average sales price per share. The shares sold at prices ranging from $42.23 to $43.16 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
| 2 | Common | Common Stock | 2022-04-14 | M | A | 1,517 | $26.66 | 53,308 | D | — | — | |
| 3 | Common | Common Stock | 2022-04-14 | M | A | 1,600 | $23.33 | 51,791 | D | — | — | |
| 4 | Common | Common Stock | 2022-04-14 | M | A | 3,503 | $11.59 | 50,191 | D | — | — | |
| 5 | Common | Common Stock | 2022-04-14 | S | D | 1,127 | $43.52 | 46,688 | D | — | — | (F3) Represents the weighted average sales price per share. The shares sold at prices ranging from $43.24 to $44.90 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
| 6 | Derivative | Employee Stock Option (right to buy) | 2022-04-14 | M | D | 3,503 | $0.00 | 25,827 | D | $11.59 · — to 2028-06-06 | 3,503 Common Stock | (F4) 25% of the shares subject to the option vested and became exercisable on April 23, 2019, and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. |
| 7 | Derivative | Employee Stock Option (right to buy) | 2022-04-14 | M | D | 1,600 | $0.00 | 24,148 | D | $23.33 · — to 2029-10-23 | 1,600 Common Stock | (F5) 25% of the shares subject to the option vested and became exercisable on October 24, 2020, and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. |
| 8 | Derivative | Employee Stock Option (right to buy) | 2022-04-14 | M | D | 1,517 | $0.00 | 38,864 | D | $26.66 · — to 2028-11-18 | 1,517 Common Stock | (F6) 20% of the shares subject to the option vested and became exercisable on October 31, 2019, and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. |